Home
Investment
News & Views
Company News
news storage
TechMARK movers: Ark shares recover
Wed, 08 Feb, 2012
INVESTMENT NEWS
Company Search
Search QCK.COM
Investment Home
News & Views
Top Stories
Charting
Company Search
Watchlist
Market Reports
Market Buzz
Company News
Economic News
New Issues
Other News
TechMARK movers: Ark shares recover
Wed, 10 Mar 2010, 16:52:00
<b>ARK Therapeutics</b> has made back some of yesterday's loss after the publication of its 2009 figures. The drug developer reported an increase in its loss from £17.6m to £21.2m. Ark still has net cash of £20.7m and this should last until the second half of 2011. Ark says that it has decided to put the development of Vitor on hold. Ark is carrying out a strategic review of the business and is prepared to consider any bids. The sale of 450 shares just before 3pm appears to have had an excessive effect on the <b>Skyepharma</b> share price. Shares in the drug developer were unchanged prior to the £284 deal but they fell a few minutes afterwards. <b>FTSE TechMARK - Risers</b> Corin Group (CRG) 62.00p +5.08% Trafficmaster (TFC) 35.00p +4.48% Phytopharm (PYM) 11.25p +4.44% Ark Therapeutics (AKT) 12.00p +4.35% DRS Data (DRS) 12.50p +4.00% Morse (MOR) 39.25p +3.97% Sinclair Pharma (SPH) 31.00p +3.33% Alterian (ALN) 150.75p +3.25% Intec Telecom Systems (ITL) 95.50p +3.24% Sepura (SEPU) 48.00p +3.23% <b>FTSE TechMARK - Fallers</b> Skyepharma (SKP) 63.00p -4.55% Asterand (ATD) 17.75p -4.23% Vislink (VLK) 26.00p -2.88% Kewill (KWL) 103.00p -2.83% Dialight (DIA) 250.00p -2.82% Parity Group (PTY) 9.75p -2.50% Puricore (PURI) 11.00p -2.27% Emblaze (BLZ) 43.75p -2.23% Innovation Group (TIG) 12.75p -1.92% NXT (NTX) 13.50p -1.82%
©2004-2009 QCK.com
